Aligos Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $57.6M | $210.5M | $104.6M |
| Jun 2022 | $45.5M | $182.5M | $71.2M |
| Sep 2022 | $42.1M | $164.1M | $86.4M |
| Dec 2022 | $42.8M | $146.7M | $81.3M |
| Mar 2023 | $37.0M | $121.7M | $78.7M |
| Jun 2023 | $36.5M | $106.1M | $90.8M |
| Sep 2023 | $31.0M | $85.9M | $70.4M |
| Dec 2023 | $59.4M | $151.5M | $135.7M |
| Mar 2024 | $68.1M | $127.9M | $24.2M |
| Jun 2024 | $41.6M | $108.8M | $45.1M |
| Sep 2024 | $38.3M | $88.4M | $35.3M |
| Dec 2024 | $99.1M | $70.1M | $37.0M |
| Mar 2025 | $34.3M | $150.7M | $73.8M |
| Jun 2025 | $32.8M | $134.7M | $18.7M |
| Sep 2025 | $37.9M | $109.8M | $41.9M |
| Dec 2025 | $35.0M | $88.5M | $18.3M |
| Mar 2026 | $32.8M | $64.6M | $30.0M |
| Jun 2026 | $34.4M | $66.3M | $30.4M |